TY - JOUR
T1 - Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity
AU - Forcet, Christelle
AU - Etienne-Manneville, Sandrine
AU - Gaude, Hélène
AU - Fournier, Laurence
AU - Debilly, Sébastien
AU - Salmi, Marko
AU - Baas, Annette
AU - Olschwang, Sylviane
AU - Clevers, Hans
AU - Billaud, Marc
N1 - Funding Information:
We are grateful to Dr A. Ashworth for kindly providing the pRK5 constructs, and to Dr M. Ware for the critical reading of the manuscript. This work was supported by a grant from the Ligue Nationale Contre le Cancer (équipe labellisée). C.F. and H.G. are recipients of a fellowship from Association pour la Recherche sur le Cancer and the Ligue Nationale Contre le Cancer, respectively.
PY - 2005/5/15
Y1 - 2005/5/15
N2 - Germline mutations of the LKB1 gene are responsible for the cancer-prone Peutz-Jeghers syndrome (PJS). LKB1 encodes a serine-threonine kinase that acts as a regulator of cell cycle, metabolism and cell polarity. The majority of PJS missense mutations abolish LKB1 enzymatic activity and thereby impair all functions assigned to LKB1. Here, we have investigated the functional consequences of recurrent missense mutations identified in PJS and in sporadic tumors which map in the LKB1 C-terminal non-catalytic region. We report that these C-terminal mutations neither disrupt LKB1 kinase activity nor interfere with LKB1-induced growth arrest. However, these naturally occuring mutations lessened LKB1-mediated activation of the AMP-activated protein kinase (AMPK) and impaired downstream signaling. Furthermore, C-terminal mutations compromise LKB1 ability to establish and maintain polarity of both intestinal epithelial cells and migrating astrocytes. Consistent with these findings, mutational analysis reveals that the LKB1 tail exerts an essential function in the control of cell polarity. Overall, our results ascribe a crucial regulatory role to the LKB1 C-terminal region. Our findings further indicate that LKB1 tumor suppressor activity is likely to depend on the regulation of AMPK signaling and cell polarization.
AB - Germline mutations of the LKB1 gene are responsible for the cancer-prone Peutz-Jeghers syndrome (PJS). LKB1 encodes a serine-threonine kinase that acts as a regulator of cell cycle, metabolism and cell polarity. The majority of PJS missense mutations abolish LKB1 enzymatic activity and thereby impair all functions assigned to LKB1. Here, we have investigated the functional consequences of recurrent missense mutations identified in PJS and in sporadic tumors which map in the LKB1 C-terminal non-catalytic region. We report that these C-terminal mutations neither disrupt LKB1 kinase activity nor interfere with LKB1-induced growth arrest. However, these naturally occuring mutations lessened LKB1-mediated activation of the AMP-activated protein kinase (AMPK) and impaired downstream signaling. Furthermore, C-terminal mutations compromise LKB1 ability to establish and maintain polarity of both intestinal epithelial cells and migrating astrocytes. Consistent with these findings, mutational analysis reveals that the LKB1 tail exerts an essential function in the control of cell polarity. Overall, our results ascribe a crucial regulatory role to the LKB1 C-terminal region. Our findings further indicate that LKB1 tumor suppressor activity is likely to depend on the regulation of AMPK signaling and cell polarization.
UR - http://www.scopus.com/inward/record.url?scp=21144470441&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddi139
DO - 10.1093/hmg/ddi139
M3 - Article
C2 - 15800014
AN - SCOPUS:21144470441
SN - 0964-6906
VL - 14
SP - 1283
EP - 1292
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 10
ER -